Cargando…

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma

In order to facilitate long-term treatment decisions, we aimed to define biomarkers defining the probability of receiving second-line (SL) targeted therapy (TT) in patients with metastatic renal cell carcinoma (mRCC) based on their characteristics present at first-line TT initiation. We analysed 152...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chrom, Pawel, Kawecki, Maciej, Stec, Rafal, Bodnar, Lubomir, Szczylik, Cezary, Czarnecka, Anna M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940724/ https://www.ncbi.nlm.nih.gov/pubmed/29737510 http://dx.doi.org/10.1007/s12032-018-1148-x

Ejemplares similares

Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model
por: Chrom, Pawel, et al.
Publicado: (2018)

Chromophobe renal cell cancer - review of the literature and potential methods of treating metastatic disease
por: Stec, Rafał, et al.
Publicado: (2009)

Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy
por: Smoter, Marta, et al.
Publicado: (2013)

The role of Tau protein in resistance to paclitaxel
por: Smoter, Marta, et al.
Publicado: (2011)

Axitinib in sequential therapy in metastatic renal cell carcinoma
por: Kuchar, Agata, et al.
Publicado: (2016)

Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma
por: Czarnecka, Anna M., et al.
Publicado: (2019)

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2016)

Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
por: Kade, Grzegorz, et al.
Publicado: (2012)

Prognostic Significance of Wnt-1, β-catenin and E-cadherin Expression in Advanced Colorectal Carcinoma
por: Stanczak, Aleksandra, et al.
Publicado: (2011)

Renal cell carcinoma with intramyocardial metastases
por: Czarnecka, Anna M, et al.
Publicado: (2014)

Choosing the right cell line for renal cell cancer research
por: Brodaczewska, Klaudia K., et al.
Publicado: (2016)

Renin angiotensin system deregulation as renal cancer risk factor
por: Sobczuk, Paweł, et al.
Publicado: (2017)

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system
por: Rokita, Marta, et al.
Publicado: (2013)

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy
por: Stec, Rafał, et al.
Publicado: (2012)

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy
por: Sigorski, Dawid, et al.
Publicado: (2020)

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma
por: Bielecka, Zofia Felicja, et al.
Publicado: (2014)

Colony, hanging drop, and methylcellulose three dimensional hypoxic growth optimization of renal cell carcinoma cell lines
por: Matak, Damian, et al.
Publicado: (2017)

Insulin-like growth factor-1 signaling in renal cell carcinoma
por: Tracz, Adam F., et al.
Publicado: (2016)

Thyroid Hormones as Renal Cell Cancer Regulators
por: Szymański, Łukasz, et al.
Publicado: (2016)

Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
por: Porta, Camillo, et al.
Publicado: (2017)

Metastasis-Initiating Cells in Renal Cancer
por: Khan, Mohammed I., et al.
Publicado: (2013)

Biology of renal tumour cancer stem cells applied in medicine
por: Matak, Damian, et al.
Publicado: (2015)

Colorectal cancer in the course of familial adenomatous polyposis syndrome (“de novo” pathogenic mutation of APC gene): case report, review of the literature and genetic commentary
por: Stec, Rafał, et al.
Publicado: (2010)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – apoptosis-regulating factors
por: Młot, Beata, et al.
Publicado: (2012)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – hypoxia-induced factors
por: Młot, Beata, et al.
Publicado: (2012)

Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators
por: Solarek, Wojciech, et al.
Publicado: (2019)

Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells
por: Khan, Mohammed I., et al.
Publicado: (2016)

Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer
por: Bodnar, Lubomir, et al.
Publicado: (2014)

Metastatic renal cell carcinoma cells growing in 3D on poly-D-lysine or laminin present a stem-like phenotype and drug resistance
por: Brodaczewska, Klaudia K., et al.
Publicado: (2019)

Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients
por: Synowiec, Agnieszka, et al.
Publicado: (2016)

Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies
por: Klemba, Aleksandra, et al.
Publicado: (2020)

Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function
por: Mielczarek, Łukasz, et al.
Publicado: (2021)

Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in  Clear - Cell Renal Cell Carcinoma (ccRCC)
por: Bielecka, Zofia F., et al.
Publicado: (2013)

Culture in embryonic kidney serum and xeno-free media as renal cell carcinoma and renal cell carcinoma cancer stem cells research model
por: Krawczyk, Krzysztof M., et al.
Publicado: (2018)

Effects of cell-cell crosstalk on gene expression patterns in a cell model of renal cell carcinoma lung metastasis
por: Kaminska, Katarzyna, et al.
Publicado: (2017)

Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma
por: Kornakiewicz, Anna, et al.
Publicado: (2013)

Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells
por: Khan, Mohammed I., et al.
Publicado: (2015)

Tracheal adenoid cystic carcinoma mimicking a thyroid tumor: A case report
por: KUKWA, WOJCIECH, et al.
Publicado: (2014)

Development of extracellular matrix supported 3D culture of renal cancer cells and renal cancer stem cells
por: Maliszewska-Olejniczak, Kamila, et al.
Publicado: (2018)

Hypoxic 3D in vitro culture models reveal distinct resistance processes to TKIs in renal cancer cells
por: Bielecka, Zofia F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9h16hfiq91i3vs6ob2gon5folq